SCOPUS 정보 검색 플랫폼

Volumn 19, Issue 8, 2004, Pages 2158-2159

Neutropenia associated with the use of low-dose methotrexate in a peritoneal dialysis patient [6]

(3) Chess, James A a Scholey, Gareth a Mikhail, Ashraf I a

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; FLUCONAZOLE; FOLINIC ACID; IMIPENEM; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TEICOPLANIN;

ADULT; ASPERGILLUS; BLOOD EXAMINATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DEATH; DISEASE ASSOCIATION; DRUG USE; DYSPNEA; HUMAN; KIDNEY FAILURE; LETTER; LEUKOCYTOSIS; LOW DRUG DOSE; LUNG ASPERGILLOSIS; LUNG INFILTRATE; MALE; MOUTH ULCER; NEUTROPENIA; PRIORITY JOURNAL; PSORIASIS; SPUTUM CULTURE; THORAX RADIOGRAPHY;

ASPERGILLOSIS; DERMATOLOGIC AGENTS; FATAL OUTCOME; HUMANS; LUNG DISEASES, FUNGAL; MALE; METHOTREXATE; MIDDLE AGED; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 4344680257 PISSN: 09310509 EISSN: None Source Type: Journal
DOI: None Document Type: Letter

Times cited : (7)

References (6)

1
- 4344642216
- British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary 46. British Medical Association, London
- British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary 46. British Medical Association, London, 2003; 555
- (2003) , pp. 555

2
- 0023909120
- Pharmacokinetics of methotrexate in continuous ambulatory peritoneal dialysis
- Janknegt R, Nube MJ, van den Hoogenband HM et al. Pharmacokinetics of methotrexate in continuous ambulatory peritoneal dialysis. Pharmaceutisch Weekblad-Scientific Edition 1988; 10: 86-89
- (1988) Pharmaceutisch Weekblad-Scientific Edition , vol.10 , pp. 86-89
- Janknegt, R.¹ Nube, M.J.² van den Hoogenband, H.M.³

3
- 0034955615
- Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice
- Grove ML, Hassell AB, Hay EM et al. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. Q J Med 2001; 94: 309-319
- (2001) Q. J. Med. , vol.94 , pp. 309-319
- Grove, M.L.¹ Hassell, A.B.² Hay, E.M.³

4
- 0028341809
- Opportunistic infection during treatment with low dose methotrexate
- Le Mense GP, Sahn SA. Opportunistic infection during treatment with low dose methotrexate. Am J Resp Crit Care Med 1994; 150: 258-260
- (1994) Am. J. Resp. Crit. Care Med. , vol.150 , pp. 258-260
- Le Mense, G.P.¹ Sahn, S.A.²

5
- 0028276909
- Invasive pulmonary aspergillosis associated with low dose methotrexate therapy for rheumatoid arthritis: A case report of treatment with itraconazole
- O'Reilly S, Hartley P, Jeffers M et al. Invasive pulmonary aspergillosis associated with low dose methotrexate therapy for rheumatoid arthritis: a case report of treatment with itraconazole. Tubercle Lung Dis 1994; 75: 153-155
- (1994) Tubercle Lung Dis. , vol.75 , pp. 153-155
- O'Reilly, S.¹ Hartley, P.² Jeffers, M.³

6
- 0021350050
- Prolonged granulocytopaenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukaemia
- Stanton L, Gerson MD, Talbot GH et al. Prolonged granulocytopaenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukaemia. Ann Int Med 1984; 100: 345-351
- (1984) Ann. Int. Med. , vol.100 , pp. 345-351
- Stanton, L.¹ Gerson, M.D.² Talbot, G.H.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.